Literature DB >> 19794095

Autoimmunity and risk for Hodgkin's lymphoma by subtype.

Sigurdur Y Kristinsson, Ola Landgren, Jan Sjöberg, Ingemar Turesson, Magnus Björkholm, Lynn R Goldin.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19794095      PMCID： PMC2754970          DOI： 10.3324/haematol.2009.010512

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  10 in total

1.  Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.

Authors:  Karin Ekström Smedby; Henrik Hjalgrim; Johan Askling; Ellen T Chang; Henrik Gregersen; Anna Porwit-MacDonald; Christer Sundström; Måns Akerman; Mads Melbye; Bengt Glimelius; Hans-Olov Adami
Journal:  J Natl Cancer Inst       Date:  2006-01-04       Impact factor: 13.506

2.  Personal and family history of autoimmune diabetes mellitus and susceptibility to young-adult-onset Hodgkin lymphoma.

Authors:  Ola Landgren; Magnus Björkholm; Scott M Montgomery; Henrik Hjalgrim; Jan Sjöberg; Lynn R Goldin; Johan Askling
Journal:  Int J Cancer       Date:  2006-01-15       Impact factor: 7.396

3.  Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives.

Authors:  Karin Ekström; Henrik Hjalgrim; Lena Brandt; Eva Baecklund; Lars Klareskog; Anders Ekbom; Johan Askling
Journal:  Arthritis Rheum       Date:  2003-04

4.  Epidemiology of Hodgkin's disease.

Authors:  B MacMahon
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

5.  Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis.

Authors:  Eva Baecklund; Anastasia Iliadou; Johan Askling; Anders Ekbom; Carin Backlin; Fredrik Granath; Anca Irinel Catrina; Richard Rosenquist; Nils Feltelius; Christer Sundström; Lars Klareskog
Journal:  Arthritis Rheum       Date:  2006-03

6.  Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia.

Authors:  Ola Landgren; Eric A Engels; Ruth M Pfeiffer; Gloria Gridley; Lene Mellemkjaer; Jørgen H Olsen; Kimberly F Kerstann; William Wheeler; Kari Hemminki; Martha S Linet; Lynn R Goldin
Journal:  J Natl Cancer Inst       Date:  2006-09-20       Impact factor: 13.506

7.  Familial aggregation of Hodgkin lymphoma and related tumors.

Authors:  Lynn R Goldin; Ruth M Pfeiffer; Gloria Gridley; Mitchell H Gail; Xinjun Li; Lene Mellemkjaer; Jørgen H Olsen; Kari Hemminki; Martha S Linet
Journal:  Cancer       Date:  2004-05-01       Impact factor: 6.860

8.  Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease.

Authors:  T M Mack; W Cozen; D K Shibata; L M Weiss; B N Nathwani; A M Hernandez; C R Taylor; A S Hamilton; D M Deapen; E B Rappaport
Journal:  N Engl J Med       Date:  1995-02-16       Impact factor: 91.245

9.  Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003.

Authors:  Ingemar Turesson; Martha S Linet; Magnus Björkholm; Sigurdur Y Kristinsson; Lynn R Goldin; Neil E Caporaso; Ola Landgren
Journal:  Int J Cancer       Date:  2007-11-15       Impact factor: 7.396

10.  Characteristics of Hodgkin's lymphoma after infectious mononucleosis.

Authors:  Henrik Hjalgrim; Johan Askling; Klaus Rostgaard; Stephen Hamilton-Dutoit; Morten Frisch; Jin-Song Zhang; Mette Madsen; Nils Rosdahl; Helle Bossen Konradsen; Hans H Storm; Mads Melbye
Journal:  N Engl J Med       Date:  2003-10-02       Impact factor: 91.245
  10 in total
  11 in total

1.  Modifiers and subtype-specific analyses in whole-genome association studies: a likelihood framework.

Authors:  Phil H Lee; Sarah E Bergen; Roy H Perlis; Patrick F Sullivan; Pamela Sklar; Jordan W Smoller; Shaun M Purcell
Journal:  Hum Hered       Date:  2011-08-17       Impact factor: 0.444

Review 2.  Adjuvants and lymphoma risk as part of the ASIA spectrum.

Authors:  Dana Butnaru; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

3.  Hodgkin lymphoma risk following infectious and chronic inflammatory diseases: a large population-based case-control study from Sweden.

Authors:  Sigurdur Y Kristinsson; Ying Gao; Magnus Björkholm; Sigrun Helga Lund; Jan Sjöberg; Neil Caporaso; Lynn R Goldin; Ola Landgren
Journal:  Int J Hematol       Date:  2015-03-11       Impact factor: 2.490

4.  Infectious, autoimmune and allergic diseases and risk of Hodgkin lymphoma in children and adolescents: a Children's Oncology Group study.

Authors:  Amy M Linabery; Erik B Erhardt; Rachel K Fonstad; Richard F Ambinder; Greta R Bunin; Julie A Ross; Logan G Spector; Seymour Grufferman
Journal:  Int J Cancer       Date:  2014-03-18       Impact factor: 7.396

5.  Autoimmunity and the risk of myeloproliferative neoplasms.

Authors:  Sigurdur Y Kristinsson; Ola Landgren; Jan Samuelsson; Magnus Björkholm; Lynn R Goldin
Journal:  Haematologica       Date:  2010-01-06       Impact factor: 9.941

6.  Autoimmune and Atopic Disorders and Risk of Classical Hodgkin Lymphoma.

Authors:  Peter Hollander; Klaus Rostgaard; Karin E Smedby; Ellen T Chang; Rose-Marie Amini; Peter de Nully Brown; Bengt Glimelius; Hans-Olov Adami; Mads Melbye; Ingrid Glimelius; Henrik Hjalgrim
Journal:  Am J Epidemiol       Date:  2015-09-06       Impact factor: 4.897

7.  Autoimmune disease is associated with a lower risk of progression in monoclonal gammopathy of undetermined significance.

Authors:  Theodóra Rún Baldursdóttir; Þorvarður Jón Löve; Gauti Kjartan Gíslason; Magnus Björkholm; Ulf-Henrik Mellqvist; Sigrun Helga Lund; Cecilie Hveding Blimark; Ingemar Turesson; Malin Hultcrantz; Ola Landgren; Sigurður Yngvi Kristinsson
Journal:  Eur J Haematol       Date:  2020-12-28       Impact factor: 3.674

Review 8.  Sarcoidosis and Cancer: A Complex Relationship.

Authors:  Thomas El Jammal; Michel Pavic; Mathieu Gerfaud-Valentin; Yvan Jamilloux; Pascal Sève
Journal:  Front Med (Lausanne)       Date:  2020-11-24

9.  Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility.

Authors:  Amit Sud; Hauke Thomsen; Philip J Law; Asta Försti; Miguel Inacio da Silva Filho; Amy Holroyd; Peter Broderick; Giulia Orlando; Oleg Lenive; Lauren Wright; Rosie Cooke; Douglas Easton; Paul Pharoah; Alison Dunning; Julian Peto; Federico Canzian; Rosalind Eeles; ZSofia Kote-Jarai; Kenneth Muir; Nora Pashayan; Per Hoffmann; Markus M Nöthen; Karl-Heinz Jöckel; Elke Pogge von Strandmann; Tracy Lightfoot; Eleanor Kane; Eve Roman; Annette Lake; Dorothy Montgomery; Ruth F Jarrett; Anthony J Swerdlow; Andreas Engert; Nick Orr; Kari Hemminki; Richard S Houlston
Journal:  Nat Commun       Date:  2017-12-01       Impact factor: 14.919

10.  Risk of mature B-cell neoplasms and precursor conditions after joint replacement: A report from the Haematological Malignancy Research Network.

Authors:  Eleanor Kane; Daniel Painter; Alexandra Smith; Maxine Lamb; Steven E Oliver; Russell Patmore; Eve Roman
Journal:  Int J Cancer       Date:  2019-11-23       Impact factor: 7.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.